By showing that SMAD 2/3 phosphorylation correlated with HCC metastatization, the authors proposed a model in which FAM46C exerts its anti-metastatic function by negatively regulating the TGF-β/SMAD pathway. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.